Published in Cancer Weekly, April 3rd, 2012
"However, the performance is still limited by the less sensitiveness to the right bound and the statistical significance of the statistics has not been fully...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
Source: Cancer Weekly (2012-04-03)
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.